Biotech

Accelerate the Development of Innovative Therapies by Working with a Strategic Biotech Consulting Partner

Increase your pipeline’s success rates and improve scalability by generating and activating biotech insights that support both early-stage and established companies.

Get Started
innovative therapies
biotech
solutions
expertise
strategies
insights
expertise
strategies
insights

Drawing from our comprehensive knowledge of the biotech landscape, and specialized expertise in rare disease markets, we equip our clients with tailored strategies to accelerate product development and optimize market access.

Access insights and approaches designed to best navigate the unique challenges of biotech and rare disease initiatives across our main areas of expertise.

Areas of Expertise

  • Allergy/Immunology
  • Cardiology/Cardiovascular Disease
  • Critical Care/Emergency Medicine
  • Dermatology
  • Endocrinology/Diabetes
  • Gastroenterology
  • Hematology
  • Infectious Diseases
  • Men’s/Women’s Health
  • Nephrology
  • Neurology
  • Oncology
  • Pain/Anesthesiology
  • Psychiatric/Mood Disorders
  • Pulmonology
  • Rare Diseases
  • Rheumatology/Auto-immune
  • Urology

Testimonials

Small Global Biotech Company

KJT is more than just a vendor, they’re a partner. They always offer a tailored approach and are very responsive.

Large Global Biotech Company

KJT helped figure out where we have been successful in influencing the market and pinpointed areas to focus on. We will be using suggestions that were provided.

Read the Latest from KJT Experts

Read More
Read More

Unlocking Participant Engagement: The Key to Meaningful Market Research

In pharmaceutical market research, one element remains consistently crucial: participant…

Read More
Read More

Navigating Successful Real-World Evidence Publications: An Interdisciplinary Journey

Publishing real-world evidence (RWE) research involves a comprehensive journey of strategic…

Read More
Read More

Go from Exam Room Conversations to Actionable Healthcare Insights

Understanding what goes on in the exam room between patients and HCPs remains a critical yet…

Read More
Read More

Patient Voice Isn’t Optional, It’s the Future of RWE

Real-world evidence (RWE) is only as meaningful as the perspectives it includes. While healthcare…

Read More
Read More

4 Use Cases for Augmenting Primary Data with Synthetic Data in Pharma Market Research

Synthetic data is not new to market research, and the healthcare insights industry is starting to…

Read More
Read More

Beyond the Hype: How Digital Twins Are Transforming Market Research

Digital twins are reshaping the way we generate insights across industries. In this webinar, we…

Read More
Read More

5 Takeaways from an Intellus Newbie

Having spent 25 years in the consumer research sector (finance, CPG, retail, tech, etc), I am used…

Read More
Read More

Reflections on PMRC 2025: The AI Train Left the Station… “Next Stop”

I have attended more than half of the PMRC conferences held over the past 16 years. Being a veteran…

Read More
Read More

10 Best Practices in Conducting Ethnography in Rare Disease Population

Rare disease patients face unique challenges that are often overlooked or misunderstood by those…

Read More
Read More

Building the Future: Why Qualitative Insights Will Thrive in the Age of AI

AI is transforming the way we collect and analyze qualitative data—but rather than replacing…

Let’s Take Research Further. Together.